Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Edwards Lifesciences Corp (EW) Stock Up 3.1% and Still Undervalued -- GF Score: 95/100
05:20pm, Friday, 22'nd May 2026
On May 22, 2026, Edwards Lifesciences Corp (EW) shares rose 3.1% to a current price of $85.78. The stock has fluctuated between $72.30 and $87.89 over the past
Is EW Overvalued? DCF Says Worth $51
08:15am, Wednesday, 13'th May 2026
On May 13, 2026, we delve into the DCF analysis for Edwards Lifesciences Corp (EW), a company that has shown varied price performance recently. The stock has ex
Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript
08:30pm, Tuesday, 12'th May 2026
Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Is Edwards Lifesciences Corp (EW) a Bargain After 3.5% Drop? GF Value Says Undervalued
07:45pm, Monday, 11'th May 2026
On May 11, 2026, Edwards Lifesciences Corp (EW) shares fell 3.5%, bringing the current price to $77.17. The stock has experienced a 52-week range of $72.30 to $
AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth
02:30pm, Sunday, 10'th May 2026
Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (
Edwards Lifesciences Announces Appointment of CFO
04:45pm, Monday, 04'th May 2026
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced the appointment of Theodora (“Doretta”) Mistras as the company's corporate vice president and chief financial offic
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue
11:50am, Saturday, 02'nd May 2026
CHICAGO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its propriet
Artisan Global Opportunities Fund Q1 2026 Portfolio Activity
11:13am, Wednesday, 29'th Apr 2026
During the quarter, we initiated new positions in Edwards Lifesciences, Eli Lilly and Roblox. In addition to Linde, Shopify and Amazon, we also added to Woodward and Spotify during the quarter. We end
Is EW Overvalued? DCF Says Worth $53
07:30am, Wednesday, 29'th Apr 2026
On April 29, 2026, we delve into the DCF analysis for Edwards Lifesciences Corp (EW), a company that has shown mixed price performance recently. Over the past w
Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference
07:05am, Tuesday, 28'th Apr 2026
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it will participate in the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026. Bernard Zovighian, chi
Head-To-Head Review: LENSAR (NASDAQ:LNSR) vs. Edwards Lifesciences (NYSE:EW)
01:44am, Monday, 27'th Apr 2026
LENSAR (NASDAQ: LNSR - Get Free Report) and Edwards Lifesciences (NYSE: EW - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on th
Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts
10:10pm, Sunday, 26'th Apr 2026
Modine Manufacturing led the way during the quarter, benefiting from secular demand in data center cooling and a well received spinoff of Modine Manufacturing's auto cooling business. Coming out of 20
EW's Q1 Earnings Beat, Revenues Match, '26 View Up, Stock Climbs
03:21pm, Friday, 24'th Apr 2026
Edwards Lifesciences beats on Q1 earnings, matches revenue estimates, lifts 2026 outlook as TAVR and TMTT growth accelerates; shares rise on stronger guidance and margin expansion.
Edwards Lifesciences Stock Surges On Heart Valve Devices Growth
12:50pm, Friday, 24'th Apr 2026
Edwards Lifesciences Corp (NYSE:EW) shares are up on Friday as the company reported strong first-quarter results, highlighting growth in its transcatheter mitral and tricuspid therapies.
Edwards Lifesciences Corp (EW) Q1 2026 Earnings Call Highlights: Strong Sales Growth and Raised Guidance Propel Optimism
02:15am, Friday, 24'th Apr 2026
Sales Growth: 12.7% year-over-year increase in Q1 2026.Total Sales: $1.65 billion in Q1 2026.TAVR Sales: $1.2 billion, 11% increase over the prior year.TMTT Sa
